Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

NCT05166889 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1132

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Tozorakimab
DRUG: Tozorakimab
DRUG: Placebo

Sponsor

AstraZeneca